Evidence map›Paper›PMID 38913662›Full record

ArticlePloS one2024

Copy number variant detection using next-generation sequencing in EYS-associated retinitis pigmentosa.

Masakazu Hiraoka, Yusaku Urakawa, Kanako Kawai, Akiko Yoshida, Junichi Hosakawa, Masaki Takazawa, Akira Inaba, Satoshi Yokota, Yasuhiko Hirami, Masayo Takahashi and 3 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Masakazu HiraokaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.ORCID 0009-0007-0911-2534
Yusaku UrakawaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Kanako KawaiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Akiko YoshidaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Junichi HosakawaDepartment of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan.
Masaki TakazawaDepartment of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan.
Akira InabaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Satoshi YokotaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Yasuhiko HiramiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Masayo TakahashiDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Osamu OharaDepartment of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan.
Yasuo KurimotoDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.
Akiko MaedaDepartment of Ophthalmology, Kobe City Eye Hospital, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is the most common inherited retinal dystrophy and a major cause of blindness. RP is caused by several variants of multiple genes, and genetic diagnosis by identifying these variants is important for optimizing treatment and estimating patient prognosis. Next-generation sequencing (NGS), which is currently widely used for diagnosis, is considered useful but is known to have limitations in detecting copy number variations (CNVs). In this study, we re-evaluated CNVs in EYS, the main causative gene of RP, identified via NGS using multiplex ligation-dependent probe amplification (MLPA). CNVs were identified in NGS samples of eight patients. To identify potential CNVs, MLPA was also performed on samples from 42 patients who were undiagnosed by NGS but carried one of the five major pathogenic variants reported in Japanese EYS-RP cases. All suspected CNVs based on NGS data in the eight patients were confirmed via MLPA. CNVs were found in 2 of the 42 NGS-undiagnosed RP cases. Furthermore, results showed that 121 of the 661 patients with RP had EYS as the causative gene, and 8.3% (10/121 patients with EYS-RP) had CNVs. Although NGS using the CNV calling criteria utilized in this study failed to identify CNVs in two cases, no false-positive results were detected. Collectively, these findings suggest that NGS is useful for CNV detection during clinical diagnosis of RP.

Indexed as

DNA Copy Number VariationsEye ProteinsHigh-Throughput Nucleotide SequencingRetinitis PigmentosaAdultFemaleHumansMaleMiddle AgedMultiplex Polymerase Chain ReactionEye ProteinsEYS protein, human

Identifiers

PMID38913662
PMCPMC11195993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.